A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer (Q43003099)
Jump to navigation
Jump to search
scientific article published on 27 June 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer |
scientific article published on 27 June 2010 |
Statements
1 reference
A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer (English)
1 reference
Danny Rischin
1 reference
Michael Friedlander
1 reference
Kenneth C Hancock
1 reference
Mark J Messing
1 reference
Claude A Stringer
1 reference
Gemma M Matthys
1 reference
Bo Ma
1 reference
Jeffrey P Hodge
1 reference
Joanne J Lager
1 reference
27 June 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference